



※ 英文原著論文のみ掲載しています。
【 2015年 】
- Goto S, Fujii H, Kono K, Nakai K, Awata R, Yonekura Y, Hirata M, Shinohara M, Nishi S, Fukagawa M.
22-Oxacalcitriol attenuates bone loss in nonobese type 2 diabetes.
Bone. 2015; 74: 153-9.
- Nishi S, Imai N, Yoshita K, Ito Y, Ueno M, Saeki T.
Utrastructural studies of IgG4-related kidney disease.
Intern Med. 2015; 54(2):147-53.
- Fujii H, Nakai K, Goto S, Nishi S.
Clinical Characteristics of the Very Elderly Patients at Hemodialysis Initiation.
Intern Med. 2015;54(6):579-83.
- Nakai K, Fujii H, Yoshikawa M, Kono K, Yonekura Y, Goto S, Ishimura T, Takeda M, Fujisawa M, Nishi S.
Effect of cinacalcet cessation on hyperparathyroidism in kidney transplant patients after long-term dialysis therapy.
Clin Exp Nephrol.2015; 19(6): 1184-8.
- Ishida R, Nakai K, Fujii H, Goto S, Hara S, Imai N, Nishi S.
Elevated expression of pentraxin3 in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with normal serum C-reactive protein.
Intern Med. 2015;54(11):1369-73.
- Yonekura Y, Fujii H, Nakai K, Kono K, Goto S, Shinohara M, Nishi S.
Anti-oxidative effect of the β-blocker Carvedilol on diabetic nephropathy in non-obese type2 diabetic rats.
Clin Exp Pharmacol Physiol. 2015 [Epub ahead of print]
- Yoshikawa M, Kitamura K, Ishimura T, Hara S, Fujisawa M, Nishi S.
A suspected case of plasma cell-rich acute renal transplant rejection associated with de novo donor-specific antibody.
Nephrology. 2015;20 Suppl 2:66-9.
- Hoshino J, Yamagata K, Nishi S, Nakai S, Masakane I, Iseki K, Tsubakihara Y.
Significance of the decreased risk of dialysis--related amyloidosis now proven by results from Japanese nationwide surveys in 1998-2010.
Nephrol Dial Transplant. 2015 [Epub ahead of print]
- Kitamura K, Nakai K, Fujii H, Ishimura T, Fujisawa M, Nishi S.
Pre-Transplant Erythropoiesis-Stimulating Agent Hypo-Responsiveness and Post-Transplant Anemia.
Transplant Proc. 2015;47(6):1820-4.
- Fujii H, Nakai K, Yonekura Y, Kono K, Goto S, Hirata M, Shinohara M, Nishi S, Fukagawa M.
The Vitamin D Receptor Activator Maxacalcitol Provides Cardioprotective Effects in Diabetes Mellitus.
Cardiovasc Drugs Ther. 2015; 29(6): 499-507.
